Building capacity across Ghana's life sciences ecosystem.
Responsible investment, scientific collaboration and regulatory engagement across pharmaceutical and health-related industries.
Optimed's life sciences division supports the development of Ghana's pharmaceutical, medical research and health-related industries through responsible investment, scientific collaboration, skills development and engagement with regulators.
Services
- Pharmaceutical raw materials
- Medical and scientific research
- Export development
- Investment promotion
- Technology transfer
- Strategic partnerships
- Regulatory engagement
- Business Division
- Optimed Life Sciences
- Sector
- Life Sciences
- What Optimed does
- Optimed's life sciences division supports the development of Ghana's pharmaceutical, medical research and health-related industries through responsible investment, scientific collaboration, skills development and engagement with regulators.
- Who it serves
- Research collaborators, regulators, investors and organisations working in pharmaceutical and health-related development.
- Services
- Pharmaceutical raw materials, Medical and scientific research, Export development, Investment promotion, Technology transfer, Strategic partnerships, Regulatory engagement
- Geography
- Ghana
- Partners
- Scientific, regulatory and investment partners across the life sciences ecosystem.
- Regulatory notes
- MedCan Ghana is a proposed project exploring opportunities within Ghana's legal framework for the cultivation and processing of medical cannabis for pharmaceutical, scientific and industrial purposes. Its development is subject to applicable laws, licensing requirements, regulatory approvals and government supervision. It is not an operating commercial product.
Let's build what matters.
Whether you are looking for an international partner, a local delivery partner, a technical solution, project coordination or a new opportunity, start the conversation with Optimed Consol.